Your Health, We Care

Home >Drug List>Selumetinib>Indications of Selumetinib

Koselugo(LuciSelume)

Release date: 2026-01-05 15:53:51     Recommended: 325

Koselugo is suitable for treating children aged 2 years and above with type 1 neurofibromatosis.